Immunoreactivity of Presenilin-1 and Tau in Alzheimer's Disease Brain

By Hendriks L.   De Jonghe C.   Lubke U.   Woodrow S.   Vanderhoeven I.   Boons J.   Cras P.   Martin J.-J.   Van Broeckhoven C.  

Experimental Neurology, Vol. 149, Iss. 2, 1998-02 ,pp. : 341-348

Elsevier

Access to resources Recommend Favorite

-Amyloid Immunoreactivity in Astrocytes in Alzheimer's Disease Brain Biopsies: An Electron Microscope Study

By Kurt M.A.   Davies D.C.   Kidd M.  

Experimental Neurology, Vol. 158, Iss. 1, 1999-07 ,pp. : 221-228

Elsevier

Access to resources Recommend Favorite

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain

By Gómez-Isla Teresa   Growdon Whitfield B.   McNamara Megan J.   Nochlin David   Bird Thomas D.   Arango Juan Carlos   Lopera Francisco   Kosik Kenneth S.   Lantos Peter L.   Cairns Nigel J.  

Brain, Vol. 122, Iss. 9, 1999-09 ,pp. : 1709-1719

Oxford University Press

Access to resources Recommend Favorite

Cytokines Associated with Amyloid Plaques in Alzheimer's Disease Brain Stimulate Human Glial and Neuronal Cell Cultures to Secrete Early Complement Proteins, But Not C1-Inhibitor

By Veerhuis R.   Janssen I.   De Groot C.J.A.   Van Muiswinkel F.L.   Hack C.E.   Eikelenboom P.  

Experimental Neurology, Vol. 160, Iss. 1, 1999-11 ,pp. : 289-299

Elsevier

Access to resources Recommend Favorite

Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation

By Dermaut B.  

Brain, Vol. 124, Iss. 12, 2001-12 ,pp. : 2383-2392

Oxford University Press

Access to resources Recommend Favorite